Videos

Melphalan flufenamide (Pepaxto; melflufen) is approved for use in combination with dexamethasone to treat adult patients with relapsed or refractory multiple myeloma.

Recent surveys have found high rates of occupational burnout among hematology and oncology pharmacists, with more than half or survey respondents reporting burnout.

Matthew Harms, a medical consultant and care center director at the MDA and associate professor of neurology at Columbia University Medical Center, to discuss new treatments and anticipated developments for ALS over the next year.

Pharmacy Times® spoke with Tomas Villanueva, DO, MBA, FACPE, SFHM, practicing health care provider, and associate vice president for clinical resources at Vizient, about vaccine hesitancy among health care workers.

In a recent Student Café series, we asked students at the Washington State University (WSU) College of Pharmacy and Pharmaceutical Sciences what drew them to study at WSU.

As accessible health care providers with links to all facets of the health care system, pharmacists are perfectly positioned to organize COVID-19 vaccine distribution in their communities.

Hannah Fish, PharmD, National Community Pharmacists Association associate director of Strategic Initiatives, discusses the next phase of the COVID-19 vaccination rollout following the FDA expanding the Pfizer-BioNTech COVID-19 vaccine EUA to include children ages 12 and older.

Erenumab-aooe (Aimovig, Amgen) is indicated for the preventive treatment of migraine in adults, making it the first approved preventive migraine treatment of its kind.

Working with colleagues or patients from different cultural backgrounds requires an open mind, especially when addressing common issues such as vaccine hesitancy.

Vericiguat (Verquvo, Merck) is indicated to reduce the risk of cardiovascular death, heart failure hospitalizations, or the need for outpatient intravenous diuretics.

Pharmacy Times® interviewed the CEO of US Pharmacopeia (USP) Ronald Piervincenzi, PhD, to discuss USP’s history, the role of the pharmacist both in that history and in USP’s work today, and USP’s outlook on the future of pharmacy.

Nasir Iqbal, PharmD, Rphl, the director of pharmacy at NYC Health + Hospitals/Lincoln, discusses the COVID-19 vaccine rollout at the Lincoln Medical Center in the Bronx.

Ed Zacharias, a managing partner of the Boston office at McDermott Will & Emery and a partner in the health industry advisory group, discusses the intersection of telemedicine and cybersecurity, specifically in relation to ransomware attacks.

Although many pharmacy students’ academic experiences were changed by the COVID-19 pandemic, leadership opportunities were still available for students who took the time to find them.

In an interview with Pharmacy Times®, Melissa Santibañez, PharmD, BCCCP, assistant professor at Nova Southeastern University College of Pharmacy, Fort Lauderdale, Florida; and critical care clinical pharmacist at Memorial Regional Hospital, Hollywood, Florida, discusses the value of a pharmacist on a patient care team.

Bhavesh Shah, RPh, BCOP; Brandon Dyson, PharmD, BCOP, BCPS; Ryan Haumschild, PharmD, MS, MBA; and Tim Peterson, PharmD, BCOP, provide advice and strategies for adopting biosimilars into clinical practice.

Rosemarie Leighton, RPh, director of pharmacy, NYC Health + Hospitals/Jacobi, discussed the coordination of COVID-19 vaccinations at the Jacobi Medical Center in the Bronx.

Building on business skills such as negotiating, managing employees, and providing culturally competent care is essential for modern pharmacists, said Shane Desselle, BSPharm, PhD.

Tivozanib was the first therapy approved by the FDA for adult patients with relapsed or refractory advanced renal cell carcinoma following 2 or more prior systemic therapies.

Suzanne Soliman, PharmD, BCMAS, and Sally Arif, PharmD, BCPS, BCCP, discussed the important role of working mothers in the pharmacy field.

For this Mother’s Day, Caroline Carney, MD, MSc, FAPM, CPHQ, explains the importance of understanding the correlation between mental health and heart health in women aged 65 years and older.

Although pharmacists have largely relied on patients coming into their facility, they should begin going out into the community to build trust in COVID-19 vaccines.

The impact of the COVID-19 pandemic on the rate of biosimilar adoption in clinical practice, updates to NCCN guideline recommendations, and financial implications associated with the utilization of biosimilars.

Caroline Carney, MD, MSc, FAPM, CPHQ, chief medical officer of Magellan Health, a board-certified internist, and a board-certified psychiatrist, discusses the impact of trauma and stress on overall health during the COVID-19 pandemic.

IQVIA researchers saw a sharp uptick in medication usage shortly before the COVID-19 pandemic began, followed by a steep fall in the first few months of the pandemic.

In addition to overall concerns about COVID-19 vaccines patients may have stronger fears about the second vaccine dose since it is often accompanied with more adverse effects.

Because several pharmaceutical companies pulled back from the federal 340B program last fall, many patients with diabetes are now seeing skyrocketing insulin prices, according to Anne Webster, NP, with UnityPoint Health.

Experts Suzanne Soliman, PharmD, BCMAS, and Sally Arif, PharmD, BCPS, BCCP, discussed their experiences and advice for handling vaccine hesitancy in part 1 of a 2-part interview on the topic.

The influence of provider buy-in for getting a biosimilar onto formulary and the role of providers in the incorporation of biosimilars are discussed.

Although many patients are hesitant about the COVID-19 vaccines, Humphreys said pharmacists are perfectly positioned to provide education.